Switching from metformin to sulfonylurea linked to cardiometabolic complications
For type-2 diabetes patients, continuing metformin treatment together with sulfonylurea is safer than switching from one to the other, a study inThe BMJ reports.Medical Xpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cardiology | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Heart | Metformin | Study